Trace Element Replenishment Study in Hemodialysis Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

December 31, 2013

Study Completion Date

January 31, 2014

Conditions
End Stage Renal Disease
Interventions
DIETARY_SUPPLEMENT

Low dose: supplemental zinc, selenium and vitamin E

"1. ZINC 25mg (AS ZINC SULFATE)~2. SELENIUM 50 mcg (AS SODIUM SELENITE)~3. VITAMIN E (D-ALPHA-TOCOPHEROL) (AS SUCCINATE) 250 IU"

DIETARY_SUPPLEMENT

Standard renal vitamin: B and C renal vitamin

"1. BIOTIN 300 MCG~2. D-PANTOTHENIC ACID (CALCIUM D-PANTOTHENATE) 10 MG~3. FOLIC ACID 1 MG~4. NIACINAMIDE 20 MG~5. VITAMIN B1 (THIAMINE MONONITRATE) 1.5 MG~6. VITAMIN B12(CYANOCOBALAMIN) 6 MCG~7. VITAMIN B2 (RIBOFLAVIN) 1.7 MG~8. VITAMIN B6 (PYRIDOXINE HYDROCHLORIDE) 10 MG~9. VITAMIN C (ASCORBIC ACID) 100 MG~10. INERT FILLER (CORNSTARCH)"

DIETARY_SUPPLEMENT

Medium dose: supplemental zinc, selenium and vitamin E

"1. ZINC 50 mg (AS ZINC SULFATE)~2. SELENIUM 75 mcg (AS SODIUM SELENITE)~3. VITAMIN E (D-ALPHA-TOCOPHEROL) (AS SUCCINATE) 250 IU"

Trial Locations (2)

T2N 1N4

University of Calgary, Calgary

T6G 2V2

University of Alberta, Edmonton

All Listed Sponsors
collaborator

Alberta Health services

OTHER

lead

Marcello Tonelli

OTHER

NCT01473914 - Trace Element Replenishment Study in Hemodialysis Patients | Biotech Hunter | Biotech Hunter